Streetbeat News

Partnerships

AMD

SSNLF

Samsung is rumored to be terminating its partnership with AMD for GPU development, as it plans to develop its own custom smartphone GPU. The underwhelming performance of the Xclipse 920 GPU, a part of the Exynos 2200, is cited as a possible reason for this decision. Samsung aims to increase competitiveness in various sectors, including automotive and AI, with an in-house GPU.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:52 pm

PLTR

Palantir Technologies Inc. (PLTR) is expanding its collaboration with PwC to combine its AI capabilities. The company has chosen the U.K. as its European headquarters for AI research and development. Palantir is also reportedly poised to secure a significant contract with the U.K.'s National Health Service (NHS), valued at approximately £480 million ($579 million). However, the financial impact of the NHS contract might not significantly influence Palantir's immediate financial results.

Portfolio Pulse from Nabaparna Bhattacharya

October 04, 2023 | 1:33 pm

BCTX

BriaCell has partnered with New York Cancer & Blood Specialists (NYCBS) for a pivotal Phase 3 study of Bria-IMT in advanced breast cancer.

Portfolio Pulse from Bill Haddad

October 04, 2023 | 1:16 pm

SNX

TD SYNNEX (NYSE:SNX) will be the exclusive North American distributor for the new suite of business products announced by Meta. The products, integrated with the Metaverse, aim to reshape business operations. The new Meta Quest 3 headset and the Meta for Work product portfolio will be launched globally in October. These products will first be available in the U.S. and Canada, followed by rollouts across Europe.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:12 pm

NRSN

NeuroSense Therapeutics' drug, PrimeC, has shown significant improvement in the survival rate of induced motor neurons in an in vitro study. The study was conducted in collaboration with the University of Southern California's Ichida Stem Cell Lab, using induced pluripotent stem cells (iPSCs) generated from people living with ALS. In a previous independent study, PrimeC outperformed several other ALS drugs in development and two ALS FDA approved drugs.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:12 pm

AMPG

AmpliTech Group, Inc (NASDAQ:AMPG) has announced new partnerships and an increase in bookings within its Satcom components subdivision, Specialty Microwave. The division has booked $1 million in Q2 and Q3 of 2023, expected to convert to revenue mostly in the first half of 2024. This is attributed to securing business from global entertainment companies such as Warner Bros., Disney, Paramount, and CBS Viacom. The bookings are for assemblies crucial for efficient signal transmission and reception across news, TV, and entertainment networks.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:11 pm

CLSD

Clearside Biomedical announced that its partner, Arctic Vision, has completed enrollment in a Phase 3 clinical trial in China for XIPERE, a treatment for Uveitic Macular Edema. This marks a significant advancement of XIPERE in the Asia-Pacific region.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:10 pm

CART

Instacart (NASDAQ:CART) and Mount Sinai Solutions have announced a partnership to provide grocery stipends for post-operative and post-partum patients insured by a Mount Sinai Solutions health plan. The program aims to ease access to fresh groceries and household essentials after major life events. Patients within the Mount Sinai Solutions network will receive $110 in Fresh Funds for care episode to pay for delivery of groceries and essentials. The partnership also includes a tailored Mount Sinai Virtual Storefront for easy shopping and delivery of provider-recommended goods via Instacart.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:09 pm

VVOS

Vivos Therapeutics has entered into strategic agreements with Ormco and On Demand Orthodontist to supply Spark Clear Aligners to its national network of providers. This has led to an increase in Vivos' share price.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:01 pm

PLTR

Palantir Technologies Inc (NYSE:PLTR) shares are trading higher following reports that the company is close to securing a five-year contract with the UK's National Health Service worth up to $579 million. The deal, which could be extended for two additional years, is awaiting final approval. Palantir also announced a collaboration with PwC to help clients realize the value of data and AI-enabled operations.

Portfolio Pulse from Adam Eckert

October 04, 2023 | 12:49 pm